Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia
Condition(s):Pancreatic NeoplasmsLast Updated:March 1, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Pancreatic NeoplasmsLast Updated:March 1, 2016Completed
Condition(s):Beta Thalassemia Major Anemia; Hemolysis; Oxidative StressLast Updated:May 14, 2019Completed
Condition(s):AbsorptionLast Updated:August 20, 2010Completed
Condition(s):Chronic Kidney Diseases; Hemodialysis; Microbiota; Oxidative Stress; InflammationLast Updated:February 26, 2024Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:June 14, 2013Completed
Condition(s):Breast CancerLast Updated:July 5, 2010Completed
Condition(s):Atrial FibrillationLast Updated:August 25, 2022Completed
Condition(s):OsteoporosisLast Updated:February 21, 2023Completed
Condition(s):Exercise and Non-exercise Effect Upon Vitamins E and CLast Updated:March 9, 2015Terminated
Condition(s):Inflammation; Cardiovascular Risk FactorLast Updated:August 29, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.